← Back to list
Newsletter Vol. 14, No. 03
Act
by Jan 31, 2004
Effective date
Dec 11, 2003
Identified
Jun 20, 2026
Summary
New Jersey's PAAD (Pharmaceutical Assistance to the Aged and Disabled) program has added Akorn, Inc. (Labeler Code 11098) to its approved manufacturers' list, effective December 11, 2003. Providers dispensing PAAD-covered legend drugs, diabetic testing supplies, and insulin from this manufacturer can now bill the program.
Get alerts when payers change rules like this one
We check New Jersey Medicaid and other payers every day and email you when a change matches your specialty and state.
Get New Jersey Medicaid alertsPolicy Monitoring is free. No card required.
What to do
by Jan 31, 2004 · 4 steps
01Pharmacy and billing staff should update internal manufacturer lists and billing system reference materials to recognize Akorn, Inc.
02(Labeler Code 11098) as an approved PAAD program manufacturer.
03Verify that point-of-sale or billing software reflects this addition to prevent claim denials for PAAD-covered prescriptions from this manufacturer.
04This primarily affects pharmacies dispensing to New Jersey PAAD beneficiaries.
Original notice
Newsletter Vol. 14, No. 03
njmmis.com · Always check the source before changing claims.
Related changes
See all New Jersey Medicaid changes →Newsletter Vol. 14, No. 01MediumEffective Jan 1, 2004 · Prior AuthorizationNewsletter Vol. 14, No. 02HighEffective Jan 21, 2004 · Provider NoticeNewsletter Vol. 14, No. 04MediumEffective Jan 1, 2004 · Prior AuthorizationNewsletter Vol. 14, No. 05MediumEffective Nov 1, 2003 · CodingBrowse every New Jersey Medicaid change in the policy list